Sofina Société Anonyme (EBR:SOF)

Market Cap	9.04B
Revenue (ttm)	1.43B
Net Income (ttm)	1.36B
Shares Out	33.05M
EPS (ttm)	40.09
PE Ratio	6.82
Forward PE	n/a
Dividend	3.50 (1.28%)
Ex-Dividend Date	May 20, 2025

Volume	3,520
Average Volume	19,102
Open	273.60
Previous Close	273.60
Day's Range	273.60 - 275.40
52-Week Range	201.20 - 284.80
Beta	1.25
RSI	56.20
Earnings Date	Sep 4, 2025

About Revance Therapeutics

Sofina Société Anonyme is a private equity and venture capital firm specializing in direct and fund of funds investments. Within direct investments, it specializes in growth capital, early, startup, later stages, mature, emerging growth, mid venture, late venture and LBO investments. The firm primarily invests in portfolio of companies that engages in digital transformation, consumer & retail, education, healthcare, life sciences, sustainable supply chains, energy and services, e-commerce, consumer goods, digital, satellite operations, industry...

• Industry: Asset Management
• Sector: Financials
• Founded: 1898
• Employees: 81
• Stock Exchange: Euronext Brussels
• Ticker Symbol: SOF